Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 295
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03819101 | Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer | ||
| NCT02666625 | Iatrogenic Effects of Treatment for Childhood Cancer Constitution of a Biological Samples Bank | ||
| NCT02813135 | European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors | ||
| NCT00180856 | Radiofrequency Ablation of Lung Tumors | ||
| NCT00920920 | An International Study on Magnetic Resonance Imaging (MRI)-Guided Brachytherapy in Locally Advanced Cervical Cancer | ||
| NCT00346645 | A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer | ||
| NCT03402568 | Alcohol Consumption and Circulating Metabolites | ||
| NCT03406247 | Adjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell Carcinoma | ||
| NCT01706016 | Local Treatment by Thermic Destruction of Primitive Breast Cancer | ||
| NCT03313206 | Neoadjuvant Treatment Associated With Maintenance Therapy by Anti-PD1 Immunotherapy in Patients With Resectable Head and Neck Mucosal Melanoma | ||
| NCT03324958 | VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients. | ||
| NCT00181168 | Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer | ||
| NCT05705687 | Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors | ||
| NCT07591493 | Adjuvant Trial in Pancreatic Neuroendocrine Tumors | ||
| NCT02040064 | Tolerability and Efficacy of Tremelimumab in Combination With Gefitinib in NSCLC Patients | ||
| NCT03617133 | Image Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer | ||
| NCT00162812 | Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin | ||
| NCT06934057 | Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma | ||
| NCT02992912 | Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours | ||
| NCT00180960 | Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia | ||
| NCT00002858 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer | ||
| NCT06514235 | Image-guided Brachytherapy for Vaginal Cancer (EMBRAVE) | ||
| NCT02455752 | Laparoscopic Extraperitoneal Total Mesorectal Excision (LE-TME): A New Feasible Technical Approach. | ||
| NCT04940325 | Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer | ||
| NCT05890781 | Engineering Immune Organoids to Study Pediatric Cancer | ||
| NCT03244956 | Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer | ||
| NCT04276376 | Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors | ||
| NCT03803735 | Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa | ||
| NCT03323424 | Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers | ||
| NCT06160596 | Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis | ||
| NCT03351296 | Two Chemotherapy Regimens Plus or Minus Bevacizumab | ||
| NCT00180973 | PHASE III TRIAL COMPARING, NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY VERSUS THE SAME NEOADJUVANT CHEMOTHERAPY FOLLOWED BY STANDARD RADIOTHERAPY ASSOCIATED WITH DAILY HYDROXYUREA IN THE TREATMENT OF LOCALLY ADVANCED UNDIFFERENTIATED CARCINOMA NASOPHARYNGEAL TYPE. | ||
| NCT00147160 | Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents | ||
| NCT00002823 | Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer | ||
| NCT00918320 | Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours | ||
| NCT00180830 | Glivec Phase II Pediatric Study | ||
| NCT02994576 | Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer | ||
| NCT05705791 | Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma | ||
| NCT02220049 | Dose Escalation of Velcade Daily Dose in Patients With Solid Tumors | ||
| NCT03308604 | AGuIX Gadolinium-based Nanoparticles in Combination With Chemoradiation and Brachytherapy | ||
| NCT00359645 | Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population | ||
| NCT02831530 | Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients | ||
| NCT03165292 | Evaluation of 2 Intensification Treatment Strategies for Neuroblastoma Patients With a Poor Response to Induction | ||
| NCT00005062 | Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission | ||
| NCT06022341 | MultiOmic characteriZation of Acute Myeloid Leukemia Evolving From myelopRoliferative Neoplasm to Identify New Targeted Therapeutic Strategies | ||
| NCT03984318 | Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs | ||
| NCT01516567 | Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation | ||
| NCT04953312 | Calprotectin, a Biomarker of COVID-19 Severity (CALPRO) | ||
| NCT06846736 | ALK Digital Pathology Outcome Predition, Multi Institutional, Restrospective Study | ||
| NCT02215720 | Temsirolimus and Cetuximab in Patients With Advanced or Metastatic Solid Tumors |
